Cardiology
Commentary
Taking cardiac pacing from boring to super cool
Ablation has hogged the electrophysiology spotlight recently, but three presentations at the 2022 Heart Rhythm Society meeting put cardiac pacing...
Conference Coverage
Endovascular benefit finally confirmed for basilar artery stroke
The study showed that endovascular therapy for basilar artery occlusion is associated with higher rates of favorable and independent outcomes.
From the Journals
Antithrombotic therapies shifting for Watchman LAA occlusion
National registry data show substantial deviation from the treatment protocols used in the pivotal randomized trials in the years following...
Feature
Topline results for dapagliflozin in HFpEF: DELIVER
AstraZeneca says regulatory submissions will be forthcoming, potentially bringing a second SGLT2 inhibitor in this space, after empagliflozin.
Conference Coverage
Bone, breath, heart, guts: Eight essential papers in primary care
Roughly one in three adults with hypertension have inadequate blood pressure control, and clinicians have two options for intensifying treatment,...
From the Journals
Takotsubo syndrome also linked to happy life events
Previous studies have shown that Takotsubo syndrome can be related to negative emotional triggers, physical triggers such as heavy physical...
From the Journals
‘Embarrassing’: High-intensity statin uptake in ASCVD patients ‘terrible’
A national study uncovered abysmal rates of usage for one of the most studied and inexpensive therapies available.
From the Journals
Traumatic brain injury linked to ‘striking’ risk for CVD, diabetes, brain disorders
Mild and moderate-to-severe TBI is linked to an increased risk for hypertension, stroke, diabetes, as well as neurological and psychiatric...
News
FDA clears mavacamten (Camzyos) for obstructive hypertrophic cardiomyopathy
Mavacamten is a first-in-class allosteric and reversible inhibitor selective for cardiac myosin that targets the underlying pathophysiology of...
News
FDA warns of pump defect with Medtronic HVAD system
Patients with the ventricular assist device could develop pump thrombosis caused by a welding defect in the internal pump, the FDA said in a...
Latest News
Pfizer recalls more quinapril because of potential carcinogen
Pfizer is not aware of any reports of adverse events related to the Accupril recall, and the company believes the benefit/risk profile remains...